Characterization of Polarized Expression of Point- or Deletion-Mutated Human BCRP/ABCG2 in LLC-PK1 Cells

Author： Takada Tappei   Suzuki Hiroshi   Sugiyama Yuichi  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.22, Iss.3, 2005-03, pp. : 458-464

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor

By Yeboah D.   Sun M.   Kingdom J.   Baczyk D.   Lye S.J.   Matthews S.G.   Gibb W.  

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 12, 2006-12 ,pp. : 1251-1258

NRC Research Press

Access to resources Recommend Favorite

Structure and Function of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)

By  

Current Drug Metabolism, Vol. 11, Iss. 7, 2010-09 ,pp. : 603-617

Bentham Science Publishers

Access to resources Recommend Favorite

Functional Analysis of SNPs Variants of BCRP/ABCG2

By Kondo Chihiro   Suzuki Hiroshi   Itoda Masaya   Ozawa Shogo   Sawada Jun-ichi   Kobayashi Daisuke   Ieiri Ichiro   Mine Kazunori   Ohtsubo Kenji   Sugiyama Yuichi  

Pharmaceutical Research, Vol. 21, Iss. 10, 2004-10 ,pp. : 1895-1903

Springer Publishing Company

Access to resources Recommend Favorite

Interaction of Isoflavones with the BCRP/ABCG2 Drug Transporter

By  

Current Drug Metabolism, Vol. 16, Iss. 2, 2015-01 ,pp. : 124-140

Bentham Science Publishers

Access to resources Recommend Favorite

Induction of proteins involved in multidrug resistance (P-glycoprotein, MRP1, MRP2, LRP) and of CYP 3A4 by rifampicin in LLC-PK 1 cells

By Magnarin M.   Morelli M.   Rosati A.   Bartoli F.   Candussio L.   Giraldi T.   Decorti G.  

European Journal of Pharmacology, Vol. 483, Iss. 1, 2004-01 ,pp. : 19-28

Elsevier

Access to resources Recommend Favorite